Mineralys Therapeutics is a startup based in the United States, 7 tracked investors.
Based in the United States, Mineralys Therapeutics is a startup. Brouky records 7 investors associated with the company.
Mineralys Therapeutics develops therapies targeting aldosterone dysregulation to improve outcomes in patients with hypertension, chronic kidney disease (CKD), and related cardio-renal-metabolic disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.